Cigna Corp. diskutieren
Cigna Corp.
WKN: A2PA9L / Symbol: CI / Name: Cigna / Aktie / Anbieter & Dienstleistungen / Large Cap /
234,50 €
-0,04 %
The Cigna Group (NYSE: CI) had its price target raised by analysts at Piper Sandler from $348.00 to $374.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target raised by analysts at Truist Financial Co. from $385.00 to $405.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $388.00 price target on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its price target raised by analysts at Barclays PLC from $382.00 to $385.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
The Cigna Group (NYSE: CI) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $371.00 price target on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE: CI) was upgraded by analysts at TD Cowen to a "strong-buy" rating.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE: CI) had its "outperform" rating re-affirmed by analysts at Royal Bank Of Canada. They now have a $371.00 price target on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE: CI) had its price target lowered by analysts at Guggenheim from $388.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE: CI) had its price target raised by analysts at Robert W. Baird from $362.00 to $374.00. They now have an "outperform" rating on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $365.00 price target on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its price target lowered by analysts at Wolfe Research from $345.00 to $325.00. They now have an "outperform" rating on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) was given a new $330.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its price target lowered by analysts at JPMorgan Chase & Co. from $428.00 to $375.00. They now have an "overweight" rating on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its price target lowered by analysts at TD Cowen from $387.00 to $333.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $415.00 to $301.00. They now have a "buy" rating on the stock.
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for CI provided by MarketBeat
Neueste Beiträge
SVB_Leerink_LLC in Ultragenyx Pharmaceutical Inc. diskutieren